Yu Lun
机构:First Hospital of China Medical University, China Medical University · ORCID:0000-0001-5165-247X
发表论文 80 篇 · 总被引 1234 次 · h-index 22
代表论文
- Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors (2022 · International Immunopharmacology · 被引 43)
- Achilles’ Heel of currently approved immune checkpoint inhibitors: immune related adverse events (2024 · Frontiers in Immunology · 被引 27)
- CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis (2022 · JCI Insight · 被引 20)
- CD6 triggers actomyosin cytoskeleton remodeling after binding to its receptor complex (2023 · Journal of Leukocyte Biology · 被引 15)
- Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy (2024 · Scientific Reports · 被引 8)
- Identifying Hub Genes and Immune Cell Infiltration for the Progression of Carotid Atherosclerotic Plaques in the Context of Predictive and Preventive Using Integrative Bioinformatics Approaches and Machine-Learning Strategies (2022 · Journal of Immunology Research · 被引 8)